NCI Office of Cancer Centers (OCC) Learning Series
The Cancer Genome Atlas (TCGA) Program:
Comprehensive Cancer Genomics Data on 5,000+ Cases Across 24 Cancer Subtypes
November 1st, 2011
2:00 to 3:30 PM EDT
The Cancer Genome Atlas (TCGA) program aims to complete the comprehensive genomic characterization of more than 11,000 tumors by the end of 2014. For each of the more than 20 tumor types being investigated, 500 cases will be characterized. Tumor tissue and a source of germline material from the same patient is available for each case and all samples are characterized for miRNA/mRNA expression, methylation, SNP/copy number and mutations (whole exome minimally).
We will review the status of TCGA in general, a description of tumor types, sample criteria and biospecimen processing, and provide a summary of the discoveries from the most well developed projects (e.g. breast, colorectal, GBM, ovarian and lung cancer) as well as provide information for how different groups can become more involved as collaborators and users of this immense, high-quality, comprehensive dataset.
Features speakers and topics include:
Kenna Shaw PhD, Deputy Director, The Cancer Genome Atlas program , NCI
Email Dr. Shaw
Jill Barnholtz-Sloan PhD, Associate Professor at the Case Comprehensive Cancer Center
Email Dr. Barnholtz-Sloan
NCI TCGA webpage
Click here to see slides of the Webinar
Click here to see the transcript of the presentation: